Actively Recruiting
Behavioral Activation Therapy for Depression in Autistic Adolescents with Below Average Intelligence
Led by Stony Brook University · Updated on 2026-09-10
18
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying a treatment approach called Behavioral Activation for Depression in Autistic Adolescents BA-A, focusing on autistic youth aged 12 to 17 years with below average intelligence IQ 60-84 who experience depression. This group, which makes up over half of the autistic community, has not been the focus of previous depression treatment research. The study aims to assess the feasibility, acceptability, and initial effects of this adapted therapy for autistic adolescents with cognitive challenges and co-occurring depressive symptoms. The treatment involves 12 weekly individual therapy sessions using a manualized approach that applies established behavioral strategies tailored to meet the needs of autistic young people. The therapy incorporates common adaptations used in mental health treatments for autism. Participants receive this Behavioral Activation therapy over approximately 12 to 13 weeks. Participants will be evaluated before treatment, after completing the 12 weekly sessions, and one month later. Assessments include standardized depression scales, measures of behavioral activation, and evaluations of treatment acceptability, appropriateness, and feasibility. Caregivers are expected to participate in all therapy sessions and assessment visits. The total study duration lasts from the baseline through the one-month follow-up after therapy completion.
CONDITIONS
Brief Title
Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
Research Team
M
Michelle Menezes, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here